Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:27:38 EDT Wed 07 Oct 2026
Enter Symbol
or Name
USA
CA



Q:ICU - SEASTAR MEDICAL HOLDING CORP - https://investors.seastarmedical.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ICU - Q0.13.03·3.193.83.19203.3629747    7.35  2.0809:07:5608:1615 min RT 2¢

Recent Trades - Last 10 of 747
Time ETExPriceChangeVolume
09:07:56Q3.19590.0059200
09:05:53Q3.200.0130
09:03:49Q3.18-0.0150
09:02:39Q3.18-0.01205
09:01:02Q3.19690.006975
09:00:53Q3.1806-0.00941
09:00:24Q3.19630.00631,750
08:57:18Q3.200.01128
08:57:17Q3.200.0135
08:57:16Q3.200.0135

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-10-07 08:16U:ICUNews ReleaseFDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
2026-10-05 08:00U:ICUNews ReleaseSeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
2026-10-02 09:43U:ICUNews ReleaseSeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
2026-10-01 08:21U:ICUNews ReleaseNew ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical's SCD Therapy for Acute Kidney Injury (AKI)
2026-09-29 08:36U:ICUNews ReleaseSeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026
2026-09-24 08:16U:ICUNews ReleaseSeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
2026-09-10 08:35U:ICUNews ReleaseSeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
2026-08-12 16:05U:ICUNews ReleaseSeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates
2026-08-06 08:35U:ICUNews ReleaseSeaStar Medical to Report Second Quarter Financial Results on August 12, 2026
2026-07-14 08:34U:ICUNews ReleaseSeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
2026-06-23 08:25U:ICUNews ReleaseSeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
2026-06-22 08:45U:ICUNews ReleaseSeaStar Medical to Present at Upcoming Investor Summit Conference
2026-05-13 16:05U:ICUNews ReleaseSeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
2026-05-06 08:20U:ICUNews ReleaseSeaStar Medical to Report First Quarter Financial Results on May 13, 2026
2026-03-30 08:20U:ICUNews ReleaseSeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
2026-03-25 16:05U:ICUNews ReleaseSeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
2026-03-18 16:05U:ICUNews ReleaseSeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026
2026-03-09 08:35U:ICUNews ReleaseSeaStar Medical to Present at the Life Sciences Investor Forum on March 11th
2026-03-05 08:20U:ICUNews ReleaseSeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI
2026-02-09 08:20U:ICUNews ReleaseSeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE(TM) (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)